Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol inhalation solution in pediatric lower respiratory tract infection with viscous sputum
CTR20171450Phase 3Active
- Sponsor
- Shaanxi Synthetic Pharmaceutical
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambroxol in pulmonary infection, sponsored by Shaanxi Synthetic Pharmaceutical. Started Dec 2017; status: active.
02
Drugs
ambroxol
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on CTR20171450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171450.